A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection
- Status
- SUSPENDED
- Phase
- PHASE1
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
ALG.APV-527 First-in-human Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors
- Status
- COMPLETED
- Phase
- NA
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Effect of Refnot on Immunity in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Status
- RECRUITING
- Phase
- PHASE1
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of BPI-452080 in Subjects With Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of GS-4528 in Adults With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1